ArticleVascular health and risk management2026
Association of Composite Metabolic Indices and Oxidative Stress Biomarkers with Coronary Atherosclerosis Detected by CT Angiography in Premenopausal Women with Metabolic Syndrome.
Article in Vascular health and risk management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metabolic syndrome (MetS) is increasingly prevalent among premenopausal women and is associated with a higher risk of subclinical atherosclerosis. This study investigated whether composite metabolic indices are more strongly associated than conventional metabolic markers with subclinical coronary artery disease (CAD) detected by coronary computed tomography angiography (CCTA). The potential contribution of oxidative stress markers to early atherosclerosis risk assessment was also evaluated in premenopausal Iranian women. Methods: In this cross-sectional case-control study, 101 women aged 30-50 years who were referred for CCTA were enrolled and classified into MetS and control groups according to The National Cholesterol Education Program, Adult Treatment Panel III (NCEP-ATP III) criteria. Demographic, biochemical, metabolic, oxidative stress, and CCTA data were collected. Atherosclerotic burden was assessed using coronary calcium score, plaque number, plaque volume, and percentage of stenosis. Composite metabolic indices, including Triglyceride glucose (TyG), Atherogenic Index of Plasma (AIP) and others were calculated and correlated with imaging findings. Results: Women with MetS exhibited significantly higher coronary plaque numbers, greater lesions volume, and more extensive calcium accumulation compared to the control group. They also demonstrated poorer metabolic health and elevated oxidative stress, as reflected by lower Total Antioxidant Capacity (TAC) and higher levels of Malondialdehyde (MDA) and Superoxide Dismutase (SOD). While traditional lipid levels showed a weak association with plaque metrics, composite indices (TyG and AIP) demonstrated a strong correlation with plaque burden and CAD risk. Oxidative stress markers may also play a supportive role in the assessment of early vascular injury. Conclusion: MetS is strongly associated with early coronary atherosclerosis in women of reproductive age. Composite indices, especially TyG and AIP, outperform conventional metabolic markers in predicting plaque burden. Their combined use with oxidative stress markers may improve early cardiovascular risk stratification and support targeted preventive strategies in premenopausal women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.